Tag: sanofiaventis group

Documents tagged

duke institute

Documents Duke University Department of Medicine Annual Report 2013

ALL IN Duke University Department of Medicine 2013 Annual Report pAge 4 pAge 13 pAge 22 CROSS- INSTITUTIONAL By bridging Dukeâs schools, centers and institutions, the Department…

Documents I.V. Enoxaparin or Unfractionated Heparin in Primary PCI: Acute and Long-term results G. M...

Slide 1 I.V. Enoxaparin or Unfractionated Heparin in Primary PCI: Acute and Long-term results G. M ONTALESCOT, DISCLOSURE : Research Grants to the Institution or Consulting/Lecture…

Documents COI Disclosure for Dr. Montalescot: Research Grants to the Institution or Consulting/Lecture Fees...

COI Disclosure for Dr. Montalescot: Research Grants to the Institution or Consulting/Lecture Fees from Abbott Vascular, Astra-Zeneca, Bayer, Biotronik, Boehringer-Ingelheim,…

Documents Sept. 13, 2012 issue of The Chronicle

The Chronicle THE INDEPENDENT DAILY AT DUKE UNIVERSITY THURSDAY, SEPTEMBER 13, 2012 ONE HUNDRED AND EIGHTH YEAR, ISSUE 16WWW.DUKECHRONICLE.COM Women’s soccer Women’s…

Documents The Business of Dying

PowerPoint Presentation The Business of Dying The Corporatization of Hospice Rob Stone MD FAAHPM All Souls Day, 2013 Woody Allen “More than any other time in history, mankind…

Documents Skalsky Et Al 2012 Mirna LCL EBV

The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines Rebecca L. Skalsky1, David L. Corcoran2, Eva Gottwein3, Christopher L. Frank1, Dong Kang1, Markus Hafner4,…

Documents Document

ARCTIC investigators COI DISCLOSURE FOR DR. MONTALESCOT: Research Grants to the Institution or Consulting/Lecture Fees from Abbott Vascular, Astra-Zeneca, Bayer, Biotronik,…